Spring 2012

Cancer Genetics and Genomics Forum



Mondays 1:00pm

(Unless otherwise noted)






Jan. 23

Dr. Sandeep Dave

Microarrays, Deep Sequencing and Beyond: The Promise and Peril of High Throughput Technologies in Cancer


Jan. 30


No Meeting



Feb. 6

Dr. Chuan-Yuan Li

Phoenix Rising and Wheel of Life: Redefining the Roles Caspases in Tumor Therapy, Tissue Regeneration, and Stem Cells


Feb. 13

Dr. Raluca Gordan

Applications of Protein Binding Microarrays to Cancer Genomics


Feb. 20

Dr. Ashley Chi

Microenvironmental Stresses and Nutrient Requirement of Tumors


Feb. 27

Dr. Herbert Hurwitz

Biomarkers for Anti-VEGF Therapy:  An Update


Mar. 5

Dr. Matthew Hirschey

Protein Acetylation Induces Hepatocellular Carcinoma



Mar. 12

Dr. Sam Mbulaiteye

(Natl. Cancer Inst.)

Endemic ,Sporadic and AIDS-related Burkitt Lymphoma: Epidemiological Patterns May Be Clue to Molecular Heterogeneity



Mar. 19

Dr. Micah Luftig

Studies at the Oncogenic Virus/Host Interface: Dynamic Regulation of Epstein-Barr Virus-Mediated B Cell Immortalization


Mar. 26

Dr. Terry Furey, UNC Chapel Hill

Integrating Genomic Data in Complex Disease Analysis


April 2

Dr. Sayan Mukherjee

Integrating Genetic and Gene Expression Evidence into Genome-wide Association Analysis of Gene Sets and a Bayesian Mixed Effects Model of Differential Expression for RNAseq Data


April 9

NO CG&G Forum



April 16

Dr. David Kirsch

Using a Genetically Engineered Mouse Model of Sarcoma to Identify miRNAs that Regulate Metastasis


April 23

Dr. W. Kimryn Rathmell,

UNC Chapel Hill

Lineberger Comprehensive Cancer Center


Tumor Heterogeneity in Renal Cell Carcinoma


April 30

Dr. William Kim,

UNC Chapel Hill Lineberger Comprehensive Cancer Center

Erythropoietin and Solid Tumorigenesis



May 7

Dr. Charles Perou,

UNC Chapel Hill

Lineberger Comprehensive Cancer Center

Therapeutic Implications of the Molecular Portraits of Breast Cancer


May 14

Dr. Donald Fox

Roles for Polyploidy in De-stabilizing the Genome


May 21

Dr. Michael Kastan

Executive Director,

Duke Cancer Institute

DNA Damage Responses: Bedside to Bench to Bedside”


June 4

Dr. Joseph Lucas

Techniques for Utilizing Public Datasets